Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-06-19
2007-06-19
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252140, C514S269000, C544S123000, C544S295000, C544S319000
Reexamination Certificate
active
10493279
ABSTRACT:
4,5-Dihydroxypyrimidine-6-carboxamides of formula (I); are described as inhibitors of HIV integrase and inhibitors of HIV replication, wherein R1, R2, R3and R4are defined herein. These compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of preventing, treating or delaying the onset of AIDS and methods of preventing or treating infection by HIV are also described
REFERENCES:
patent: 4636508 (1987-01-01), Brewer et al.
patent: 5420129 (1995-05-01), Breu et al.
patent: 5654311 (1997-08-01), Kurtz et al.
patent: 6306891 (2001-10-01), Selnick et al.
patent: 6841558 (2005-01-01), Anthony et al.
patent: 6919351 (2005-07-01), Anthony et al.
patent: 2003/0055071 (2003-03-01), Anthony et al.
patent: 2004/0106627 (2004-06-01), Gardelli et al.
patent: 2004/0110804 (2004-06-01), Walker et al.
patent: 2004/0127708 (2004-07-01), Fuji et al.
patent: 2004/0204498 (2004-10-01), Walker et al.
patent: 2004/0229892 (2004-11-01), Naidu et al.
patent: 2004/0229909 (2004-11-01), Kiyama et al.
patent: 2005/0010048 (2005-01-01), Zhuang et al.
patent: 2339272 (2000-03-01), None
patent: 1422218 (2004-05-01), None
patent: 601886 (2004-06-01), None
patent: WO 99/32117 (1999-07-01), None
patent: WO 99/62520 (1999-12-01), None
patent: WO 99/62897 (1999-12-01), None
patent: WO 00/51990 (2000-09-01), None
patent: WO 01/00578 (2001-01-01), None
patent: WO 01/85700 (2001-11-01), None
patent: WO 02/02646 (2002-01-01), None
patent: WO 02/06246 (2002-01-01), None
patent: WO 2004/004657 (2004-01-01), None
patent: WO 2004/062613 (2004-07-01), None
Miles, Medline Abstract (Community Pract, vol. 78, Issue 8, pp. 292-294) Aug. 2005.
van Heeswijk et al., PubMed Abstract (Antivir Ther. 6(4):201-29) Dec. 2001.□□
Marcus et al., PubMed Abstract (Intervirology 45(4-6):260-6) 2002.
Ratner, L., et al., “Complete Nucleotide Sequence of the AIDS Virus, HTLV-III”, Nature, vol. 313, pp. 277-284, (1985).
Toh, H., et al., “Close Structural Resemblance Between Putative Polymerase of a Drosphila Transposable Genetic Element 17.6 and Pol Gene Product of Moloney Murine Leukemia Virus”, EMBO Journal, vol. 4, No. 5, pp. 1267-1272, (1985).
Power, M.D., et al., “Nucleotide Sequence of SRV-1, a Type D Simian Acquired Immune Deficiency Syndrome Retrovirus”, Science, vol. 231, pp. 1567-1572, (1986).
Pearl, L.H., et al., “A Structural Model for the Retroviral Proteases”, Nature, vol. 329, pp. 351-354, (1987).
Ivin, B.A., et al., “Unsaturated Hydantoin Derivatives, XI.”, vol. 10, No. 11, (1976).
Culbertson,Townley P., et al., “Synthesis of 5,6-Dihydroxy-2-phenyl-4-pyrimidinecarboxylic Acid, Methyl Ester, a Corrected Sturcture”, Journal of Heterocyclic Chemistry, vol. 16, pp. 1423-1424, (1979).
CAPLUS No. 1992:571466. “Preparation of 2-Phenylpyrimidines as Agrochemical Fungicides”, 1992, Abstract of DE4029654, plus compunds therein indexed in the CAS Registry File.
Derwent Abstract No. 2000-237546, “Antiviral Agent Containing New or Unknown Pyrazine, Pyrimidine, Pyridazine or Triazine Caboxamide”, 2000, Abstract of WO 00/10569 (See Cite No. 13—CA2339272).
Derwent Abstract No. 2003-505255/47, “HIV Integrase Inhibitor Comprises New and Known Cyclic Compunds”, 2003, Abstract of WO 03/47564.
Sunderland, C., et al., “6-Carboximido-5,4-Hydroxypyrimidinones: A New Class of Heterocyclic Ligands and Their Evaluation as Gadolinium Chelating Agents”, Inorganic Chemistry, vol. 40, No. 26, pp. 6746-6756 (2001).
Mauss, S., et al., “Influence of HIV Protease Inhibitors on Hepatitis C Viral Load in Individuals with HIV and HCV Coinfection”, Program and Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy, p. 218 (1997).
Di Francesco Maria E.
Gardelli Cristina
Harper Steven
Matassa Victor G.
Murgalia Ester
Camara Valerie J.
Istituto Di Ricerche Di Biologia P. Angeletti S.p.A.
Rao Deepak
Walton Kenneth R.
LandOfFree
Dihydroxypyrimidine carboxamide inhibitors of HIV integrase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dihydroxypyrimidine carboxamide inhibitors of HIV integrase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydroxypyrimidine carboxamide inhibitors of HIV integrase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3815523